OncologyPRO, in partnership with medwireNews, brings you updates each day in the field of medical oncology.
Watch leading oncology experts in ESMO's latest scientific and educational videos.
Collection of links to the latest cancer related articles in top medical journals: Annals of Oncology, The Lancet, JAMA, NEJM, BMJ and Nature Medicine
Haven't had much time lately? Here's what you may have missed in the last few months
Webcasts produced by leading oncology experts
New! Read patient cases produced by oncology experts or create and store your own cases
Find here all the information related to anti-cancer agents as described in the ESMO Handbook on Clinical Pharmacology of Anti-Cancer Agents.
Number of factsheets of validated biomarkers designed to assist you in your daily practice.
ESMO Clinical Trial Resources are designed to support you with designing, participating in and reviewing clinical trials
Find all ESMO 2014 abstracts classified by drug.
Find the most common oncology abbreviations.
Meeting reports from past ESMO organised and ESMO supported meetings.
Annotated links to the top biomarker journals related to oncology, as per the latest impact factor ranking and open access journals on biomarkers.
Educational slides on Cancer Prevention, Clinical Trials, Colorectal Cancer and Molecular Biology
The 2016 edition of ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology is now available
Our 2016 Clinical Practice Guidelines are now online.
Download the new version of our App with the latest Pocket Guidelines for professionals and Guides for Patients
Information, treatment algorithms and educational materials for healthcare professionals and patients about skin problems that may occur when being treated with anti-EGFR drugs
Information, treatment algorithms and educational materials for healthcare professionals and patients relating to the management of dermatological toxicities in patients treated with multikinase inhibitors.
Information and education online resource for healthcare professionals on drug-drug interactions which can arise from the use of kinase inhibitors
ESMO has developed a set of organ-specific tools designed to assist oncologists in their daily practice.
ESMO Consensus Conferences discuss key questions in certain disease areas and complement the ESMO Clinical Practice Guidelines
Useful information and updates created by ESMO for cancer patients
ESMO members: the recent ESMO Handbooks are available for browsing online to allow you to easily access the sections most relevant to you.
A simplified yet comprehensive overview on oncological malignancies, their biology, diagnosis, staging, treatment and follow-up, which are necessary for basic patient treatment
ESMO members: Browse through the ESMO Glossary in Molecular Biology of Cancer and Molecular Techniques online
Discover the User's Manual for Oncology Clinicians: “Clinician’s notes” for each of the 16 chapters of the patient guide.
Here, ESMO members can gain direct access to journals available to Annals of Oncology. You can also find links to interesting journals in the fields of Medical Oncology, Haematology and Biomarkers.
KEYNOTE-045 Supports Pembrolizumab For Platinum-Refractory Urothelial Cancer
ProtecT At 10 Years Shows Risk–Benefit Ratio For Active Monitoring in Localised Prostate Cancer
Radium-223 Treatment Combinations Feasible For Metastatic Castration-Resistant Prostate Cancer
Atezolizumab in Patients With Locally Advanced and Metastatic Urothelial Carcinoma
Olaparib ‘Highly Effective’ In DNA Repair-Deficient Metastatic Prostate Cancer
Nivolumab Boosts Advanced ccRCC Overall Survival
Abiraterone Acetate Prolongs Survival in Metastatic Prostate Cancer
Prostate Cancer in Young Men
Enzalutamide Improves Overall Survival for Advanced Castration-Resistant Prostate Cancer
Chemohormonal Therapy Extends Metastatic Prostate Cancer Survival
Enzalutamide in Chemotherapy-Naive mCRPC
Sequential pathogenesis of metastatic VHL mutant clear cell renal cell carcinoma: putting it together with a translational perspective
Anti-tumour activity of platinum compounds in advanced prostate cancer—a systematic literature review
Second-line single-agent versus doublet chemotherapy as salvage therapy for metastatic urothelial cancer: a systematic review and meta-analysis
Should docetaxel be standard of care for patients with metastatic hormone-sensitive prostate cancer? Pro and contra
Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015
Alternate sunitinib schedules in patients with metastatic renal cell carcinoma
Radiotherapy or chemotherapy for clinical stage IIA and IIB seminoma: a systematic review and meta-analysis of patient outcomes
New agents for prostate cancer
Blocking PD-L1 pathway: Changing landscape in urothelial cancer
Targeting AR axis in prostate cancer
ESMO 2016 - Highlights Session
European Multidisciplinary Meeting on Urological Cancers 2015 (EMUC)
ESMO Preceptorship on Prostate Cancer 2015 (Barcelona)
ESMO Preceptorship on Prostate Cancer 2015
5th Scientific Meeting of the Spanish Oncology Genitourinary Group (SOGUG)
ESMO Preceptorship on Prostate Cancer 2014
ESMO 2014 - Genitourinary tumours, prostate
ESMO 2014 - Genitourinary tumours, non-prostate
ESMO Essentials for Clinicians: Genitourinary Tract Tumours
2015 European Cancer Congress – Scientific Meeting Report Genitourinary Malignancies Extract
ESMO 2014 Congress Scientific Meeting Report - Genitourinary Cancers Extract
Prostate cancer: ESMO Consensus Conference Guidelines 2012
Renal cell cancer
Testicular seminoma and non-seminoma
Rational Treatment Delivery in Clinical Stage I and II Testicular Germ Cell Tumours (Including Long-Term Toxicities)
PD-L1 in Cancer: ESMO Biomarker Factsheet
Hints for personalised medicine in genitourinary cancers
Access the latest OncologyPRO content on Genitourinary Cancers.
Access test questions